[HTML][HTML] Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss
L Rüland, F Andreatta, S Massalini… - Nature …, 2023 - nature.com
Fibrolamellar carcinoma (FLC) is a lethal primary liver cancer, affecting young patients in
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss
L Rüland, F Andreatta, S Massalini… - Nature …, 2023 - pure.knaw.nl
Fibrolamellar carcinoma (FLC) is a lethal primary liver cancer, affecting young patients in
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss
L Rüland, F Andreatta, S Massalini… - Nature …, 2023 - ui.adsabs.harvard.edu
Fibrolamellar carcinoma (FLC) is a lethal primary liver cancer, affecting young patients in
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss.
L Rüland, F Andreatta, S Massalini… - Nature …, 2023 - search.ebscohost.com
Fibrolamellar carcinoma (FLC) is a lethal primary liver cancer, affecting young patients in
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss
L Rüland, F Andreatta, S Massalini… - Nature …, 2023 - ideas.repec.org
Fibrolamellar carcinoma (FLC) is a lethal primary liver cancer, affecting young patients in
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss.
L Rüland, F Andreatta, S Massalini… - Nature …, 2023 - europepmc.org
Fibrolamellar carcinoma (FLC) is a lethal primary liver cancer, affecting young patients in
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss
L Rüland, F Andreatta, S Massalini… - Nature …, 2023 - pubmed.ncbi.nlm.nih.gov
Fibrolamellar carcinoma (FLC) is a lethal primary liver cancer, affecting young patients in
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss
L Rüland, F Andreatta, S Massalini… - Nature …, 2023 - econpapers.repec.org
Fibrolamellar carcinoma (FLC) is a lethal primary liver cancer, affecting young patients in
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
[HTML][HTML] Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss
L Rüland, F Andreatta, S Massalini… - Nature …, 2023 - ncbi.nlm.nih.gov
Fibrolamellar carcinoma (FLC) is a lethal primary liver cancer, affecting young patients in
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited …
[引用][C] Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss
pure.knaw.nl
Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte
transdifferentiation through cooperative BAP1 and PRKAR2A loss – Fingerprint — Royal …
transdifferentiation through cooperative BAP1 and PRKAR2A loss – Fingerprint — Royal …